THE EFFECT OF NASYA KARMA AND MATRA BASTI WITH KSHEERABALA TAILA IN GREEVASTAMBHA W.S.R. TO CERVICAL SPONDYLOSIS

RANDOMIZED COMPARATIVE CLINICAL STUDY TO EVALUATE THE EFFECT OF NASYA KARMA AND MATRA BASTI WITH KSHEERABALA TAILA IN THE MANAGEMENT OF GREEVASTAMBHA W.S.R. TO CERVICAL SPONDYLOSIS - nil

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/04/085480

Enrollment

Registered

2025-04-24

Start date

Unknown

Completion date

Unknown

Last updated

2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M472- Other spondylosis with radiculopathy

Interventions

Intervention1: Ksheerabala Taila: Ksheerabala Taila Matra Basti for 14 consecutive days Control Intervention1: Ksheerabala Taila: Ksheerabala Taila Nasya Karma for 14 Consecutives Days

Eligibility

Inclusion criteria

Inclusion criteria: (1)Patients suffering from classical signs and symptoms of Greevastambha w.s.r. to cervical spondylosis. (2)Patient willing and able to participate in the study for 14 days and follow up period of 30 days. (3)Neurological deficits consistent with cervical spine pathology.

Exclusion criteria

Exclusion criteria: (1)Patients suffering from any acute diseases, infectious diseases, metabolic diseases, chronic diseases (like rheumatoid Arthritis, Uncontrolled DM, Gout, TB, SLE, Ankylosing spondylitis etc.). (2)Patient contraindicated for Nasya Karma. (3)Acute trauma to the cervical spine.

Design outcomes

Primary

Measure	Time frame
Reducation in pain in cervical spondylosis patientsTimepoint: Follow up on 30th and 45th day of enrollment	—

Secondary

Measure	Time frame
Reducation in Stiffness in cervical spondylosis PatientsTimepoint: Follow up on 30th and 45th day of enrollment	—

Countries

India

Contacts

Public ContactDr Rajeev Kumar Pandey

Madan Mohan Malviya Goverment Ayurved collage udaipur Rajasthan

rajeevpanchakarma@gmail.com07976104054

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 11, 2026